HSPH News |
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
HSPH News Boston, MA – A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other … Development of a therapeutic monoclonal antibody that targets secreted fatty …Science Magazine all 18 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.